ES8203368A1 - Procedimiento de producir amidas ciclicas - Google Patents

Procedimiento de producir amidas ciclicas

Info

Publication number
ES8203368A1
ES8203368A1 ES502064A ES502064A ES8203368A1 ES 8203368 A1 ES8203368 A1 ES 8203368A1 ES 502064 A ES502064 A ES 502064A ES 502064 A ES502064 A ES 502064A ES 8203368 A1 ES8203368 A1 ES 8203368A1
Authority
ES
Spain
Prior art keywords
lower alkyl
integer
cyclic amides
hydrogen
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES502064A
Other languages
English (en)
Other versions
ES502064A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
USV Pharmaceutical Corp
Original Assignee
USV Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by USV Pharmaceutical Corp filed Critical USV Pharmaceutical Corp
Publication of ES502064A0 publication Critical patent/ES502064A0/es
Publication of ES8203368A1 publication Critical patent/ES8203368A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/04—1,3-Thiazines; Hydrogenated 1,3-thiazines
    • C07D279/08—1,3-Thiazines; Hydrogenated 1,3-thiazines condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

PROCEDIMIENTO PARA PRODUCIR AMIDAS CICLICAS. CONSISTE EN ACILAR UNA AMINA DE FORMULA GENERAL (I) CON UN ACIDO MERCAPTO O DERIVADO ACILANTE EQUIVALENTE (II). OPCIONALMENTE SE CONVIERTE EL GRUPO -COY EN EL ACIDO LIBRE (Y=OH) O BIEN SE OXIDA EL PRODUCTO EN QUE R5 ES H PARA OBTENER EL BISULFURO O BIEN SE DERIVA EL PRODUCTO EN QUE R5 ES H PARA INTRODUCIR SUSTITUYENTES REPRESENTATIVOS DE R5 DIFERENTES DE H. SE OBTIENE EL COMPUESTO (III).
ES502064A 1980-05-12 1981-05-09 Procedimiento de producir amidas ciclicas Expired ES8203368A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/148,083 US5200416A (en) 1980-05-12 1980-05-12 Cyclic amides

Publications (2)

Publication Number Publication Date
ES502064A0 ES502064A0 (es) 1982-04-01
ES8203368A1 true ES8203368A1 (es) 1982-04-01

Family

ID=22524186

Family Applications (1)

Application Number Title Priority Date Filing Date
ES502064A Expired ES8203368A1 (es) 1980-05-12 1981-05-09 Procedimiento de producir amidas ciclicas

Country Status (18)

Country Link
US (1) US5200416A (es)
EP (1) EP0039804B1 (es)
JP (1) JPS577470A (es)
KR (1) KR850001088B1 (es)
AT (1) ATE21511T1 (es)
AU (1) AU546218B2 (es)
DE (1) DE3175150D1 (es)
DK (1) DK206881A (es)
ES (1) ES8203368A1 (es)
FI (1) FI811424L (es)
IL (1) IL62782A0 (es)
IN (1) IN152326B (es)
NO (1) NO811599L (es)
NZ (1) NZ197048A (es)
SU (1) SU1304748A3 (es)
YU (1) YU120481A (es)
ZA (1) ZA812941B (es)
ZW (1) ZW10881A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2672598A1 (fr) * 1991-02-11 1992-08-14 Adir Nouveaux inhibiteurs de n-myristoyltransferase, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
AU7724496A (en) * 1995-11-09 1997-05-29 Monsanto Company An improved method for preparation of substituted tetrahydroisoquinolines
US5627282A (en) * 1996-01-03 1997-05-06 Yukong Limited Process for the preparation of optically pure 1,2,3,4-tetrahydro-3-isoquinolinecarboxylic acid and its derivatives
EP2518070A1 (en) * 2011-04-29 2012-10-31 Almirall, S.A. Pyrrolotriazinone derivatives as PI3K inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5572169A (en) * 1978-11-27 1980-05-30 Tanabe Seiyaku Co Ltd Isoquinoline derivative and its preparation
DE3063420D1 (en) * 1979-03-26 1983-07-07 Takeda Chemical Industries Ltd Tetrahydroisoquinolines, their production and the compounds and pharmaceutical compositions containing them for use in the prevention or treatment of hypertension
GB2048863B (en) * 1979-05-16 1983-06-15 Morton Norwich Products Inc Tetrahydroisoquinoline-3-carboxylic acids
DE2937779A1 (de) * 1979-09-19 1981-04-09 Hoechst Ag, 6000 Frankfurt Aminosaeurederivate und verfahren zu ihrer herstellung
FR2487829A2 (fr) * 1979-12-07 1982-02-05 Science Union & Cie Nouveaux imino acides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
US4251444A (en) * 1980-04-07 1981-02-17 American Home Products Corporation Thiazepino-[4,3-b]-isoquinoline-1,5-dione derivatives and precursors

Also Published As

Publication number Publication date
ES502064A0 (es) 1982-04-01
EP0039804B1 (en) 1986-08-20
EP0039804A1 (en) 1981-11-18
AU546218B2 (en) 1985-08-22
KR850001088B1 (ko) 1985-07-27
JPS577470A (en) 1982-01-14
SU1304748A3 (ru) 1987-04-15
ATE21511T1 (de) 1986-09-15
IL62782A0 (en) 1981-07-31
YU120481A (en) 1983-12-31
NZ197048A (en) 1984-04-27
US5200416A (en) 1993-04-06
ZW10881A1 (en) 1981-07-29
ZA812941B (en) 1982-05-26
KR830006210A (ko) 1983-09-20
NO811599L (no) 1981-11-13
AU7045081A (en) 1981-11-19
IN152326B (es) 1983-12-17
FI811424L (fi) 1981-11-13
DE3175150D1 (en) 1986-09-25
DK206881A (da) 1981-11-13

Similar Documents

Publication Publication Date Title
ATE23716T1 (de) 5,6,7-trinor-4,8-inter-m-phenylen-prostaglandin i2-derivate.
YU82304A (sh) Kristalni 3,4,4-trisupstituisani-piperidinil-n-alkilkarboksilati, intermedijeri i postupak za dobijanje
ES8307719A1 (es) "procedimiento de preparar amidoaminoacidos n-substituidos".
ES8405371A1 (es) Un procedimiento para la preparacion de derivados del indol.
ES8503667A1 (es) Un procedimiento para la preparacion de nuevos derivados de 2-oxo-imidazolina.
MY100115A (en) Nitrogen containing heterocyclic compounds, and their production and use.
ES8203368A1 (es) Procedimiento de producir amidas ciclicas
ES463424A1 (es) Procedimiento de preparacion de lactamas sustituidas en n.
ES2001953A6 (es) Procedimiento para la obtencion de compuestos de b -lactama.
ES8200113A1 (es) Un procedimiento para la preparacion de derivados de cefalosporina.
ES8706129A1 (es) Un procedimiento para la preparacion de derivados de imidazol triciclicos
ES8301931A1 (es) Un procedimiento para la preparacion de nuevos imidazoles.
ES8705464A1 (es) Un procedimiento para la preparacion de nuevos peptidos.
ES471267A1 (es) Procedimiento para la preparacion de alquilo inferior 2-tri-(inferior) alquilsililacetileno-n-carbetoxiglicinatos y ami-no acidos derivados de ellos
ES8406507A1 (es) Procedimiento para la preparacion de hexanorbrassinolid-22-eteres
ES8100304A1 (es) Un procedimiento para preparar derivados de indol policiclicos
ES466682A1 (es) Procedimiento para la obtencion de derivados del acido inde-no - 2.1-b-tiopen-2-oxamico
ES8401761A1 (es) Un procedimiento para la preparacion de derivados de 1-(3,4,5-trimetoxicinamoil)-4-aminocarboniletil-piperazina sustituidos.
IL107043A0 (en) Novel pharmaceutically active flavilium compounds
ES8705426A1 (es) Un procedimiento para la preparacion de un derivado de piperazina.
ES8303325A1 (es) "procedimiento para la preparacion de prostaglandinas".
ES8608538A1 (es) Procedimiento para la preparacion de esteres alquilicos de alfa-l-aspartil-l-fenilalanina
ES2009283A6 (es) Procedimiento para preparar nuevos aminoacilatos de glicerol-acetal.
MX9801926A (es) Procedimiento para la preparacion de derivados de arilalquinil-n-hidroxiurea que tienen actividad inhibidora de lipoxigenasa.
ES2056025A1 (es) Nuevos derivados de indol.